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The purpose of this report is to examine our attitudes towards end-of-life care and 
assess the systems of reimbursement and quality measurement that support and sustain it. 
This report is divided into two primary sections: the first, Culture, explores the culture of 
end-of-life care, from its historical roots and development to its slow integration into 
modern medicine. The second, Infrastructure, focuses on the Medicare Hospice Benefit 
and quality measurement under the Affordable Care Act. Under healthcare reform, 
reimbursement is now more than ever tied to quality and as such the two systems operate 
in close concert. Their influence on the provision and assessment of end-of-life care is 
significant, and this report analyzes flaws in each that undermine their potential to truly 
advance quality, person-centered care. This report ends with recommendations for 
improvement for both reimbursement and quality measurement, with the sincere hope 
that by strengthening the structures that support end-of-life care, we will better support 






Table of Contents 
Introduction ............................................................................................................. 1	  
I. CULTURE 3	  
Death Panels ............................................................................................................ 3	  
Looking Back at End of Life .................................................................................. 7	  
Hospice and Palliative Care .................................................................................. 10	  
The Culture of Care .............................................................................................. 15	  
II. INFRASTRUCTURE 21	  
Medicare and Hospice ........................................................................................... 21	  
A Growing Industry ..................................................................................... 22	  
The Medicare Hospice Benefit .................................................................... 23	  
The Beginning of Reform ............................................................................ 28	  
Quality Measurement ............................................................................................ 32	  
“A Good Death” ........................................................................................... 32	  
Quality Under the ACA ............................................................................... 36	  
HIS, CAHPS, and Patient Preference .......................................................... 40	  
Recommendations ................................................................................................. 45	  
Medicare Hospice Benefit ............................................................................ 45	  
Hospice Quality Reporting Program ............................................................ 47	  
Conclusion ............................................................................................................ 50	  
Appendices ............................................................................................................ 51	  
Appendix A: Hospice Item Set .................................................................... 51	  
Appendix B: NQF Endorsed Measures ........................................................ 54	  
Appendix C: CAHPS Hospice Survey ......................................................... 55	  










The realization that we each will die comes, for many, with a natural impulse to 
push that reality away. We focus instead on the here-and-now, we count our blessings, 
we live our lives, and we move the business of our ending to a later date. The story of 
hospice and palliative care’s development in the United States is really no different. A 
late arrival to our shores, an outgrowth of a faith-based tradition of service, the question 
of how we treat our dying has really only taken root in the last thirty years. Since then, 
growth has been slow. Individuals, care providers, and policymakers have made 
incremental movement towards a more open consideration of care at end of life; how 
with advance planning and open communication, the process of dying does not have to be 
something merely to fear, but an opportunity to spend quality time, free of pain and 
suffering, with those you love.  
What this report seeks to do is better understand our attitudes towards end-of-life 
care and analyze the systems that structure and sustain it. Section one – Culture – 
explores the historical roots of end-of-life care and its development in the United States, 
and considers its halting integration into the mainstream due to traditions of medical 
culture and our deference to them. Understanding the changing attitudes towards death 
and dying sheds light on the common resistance of both individuals and their care 
providers to face death, as they pursue continued treatment even when the evidence-
based benefits of hospice and palliative care are clear. Revealing the human experience of 
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needing (or needing to provide) end-of-life care provides the human framework for an 
analysis of the policies that give individuals access to it.  
Section two – Infrastructure – examines the two primary supports of end-of-life 
care: first, the mechanism that pays for it (reimbursement), and second, the evaluative 
measures that ensure its quality. Insurance reimbursement deeply influences patient 
enrollment patterns, provider demographics, and the services they deliver, while quality 
measurement theoretically ensures accountability for the services provided and paid for 
by insurance. As the Affordable Care Act seeks to transition the American medical 
system from fee-for-service to pay-for-performance, now more than ever is quality tied to 
reimbursement and as such, they stand in close connection. Together they deeply 
influence how end-of-life care is delivered, monitored, and sustained, and any effort to 
understand our personal or cultural reticence to discussing options at end of life is futile 
without also analyzing the policies that make those options available to us.  
An effort to understand end-of-life care, from history to culture, from person to 
provider, from mythmaking to policy, is an effort to understand how the experience of 
dying has become what it is, and to use that knowledge to consider and recommend a 






Death Panels  
Late summer of 2009 marked the opening movement of what would become – 
and in many ways, remains – a fierce debate about the intent and values of national 
healthcare reform. One month after Speaker of the House Nancy Pelosi introduced the 
Affordable Health Care for America Act (H.R. 3962), and as the Senate moved to 
introduce its version, America’s Healthy Future Act (S.1796), Sarah Palin, the former 
governor of Alaska and failed vice presidential candidate, published on Facebook a 
“Statement on the Current Health Care Debate.” She wrote: 
 
As more Americans delve into the disturbing details of the nationalized 
health care plan that the current administration is rushing through Congress, our 
collective jaw is dropping, and we’re saying not just no, but hell no! 
The Democrats promise that a government health care system will reduce 
the cost of health care, but as the economist Thomas Sowell has pointed out, 
government health care will not reduce cost; it will simply refuse to pay the cost. 
And who will suffer the most when they ration care? The sick, the elderly, and the 
disabled, of course. The America I know and love is not one in which my parents 
or my baby with Down Syndrome will have to stand in front of Obama’s “death 
panel” so his bureaucrats can decide, based on a subjective judgment of their 
“level of productivity in society,” whether they are worthy of health care. Such a 
system is downright evil. 
Health care by definition involves life and death decisions. Human rights 
and human dignity must be at the center of any health care discussion.1  
 
Palin’s statement was directed at her base of small-government conservatives, 
speaking directly to their fears of encroachment by federal powers. Raising the specter of 
socialism through repeated emphasis on the “nationalizing” of healthcare, Palin’s words 
                                                
1 Palin, “Obama and the Bureaucratization of Health Care.” 
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served as a powerful voice against reform. Riding a wave of fame, albeit on the decline, 
from the 2008 presidential election, Palin had a pulpit from which she could influence the 
dialogue. Statements such as those she posted in 2009, and the many that followed, 
shaped public perception both on the reform’s ideological intent as well as its practical 
implications.2  
Nowhere was this clearer, or more damaging, than in her 2009 introduction of 
“death panels.” A reincarnation of earlier statements made by the conservative 
commentator Betsy McCaughey3, Palin’s “death panels” referred to a specific section of 
the house bill that would have allowed Medicare coverage for “voluntary advance care 
planning” sessions during annual well visits.4 In her comments, Palin also drew attention 
to the proposed formation of the Independent Medicare Advisory Council, a five-member 
committee whose formation would serve as a formal body to issue Medicare cost saving 
recommendations to the president. Palin characterized this council as judges on the death 
panels:  
[A]n unelected, largely unaccountable group of experts charged with 
containing Medicare costs… who would guide decisions regarding that [quoting 
President Obama] ‘huge driver of cost… the chronically ill and those toward the 
end of their lives.’ Given such statements, is it any wonder that many of the sick 
and the elderly are concerned that the Democrats’ proposals will ultimately lead 
to rationing of their health care by – dare I say it – death panels?”5  
 
                                                
2 Belluck, “Coverage for End-of-Life Talks Gaining Ground.”; Weiner, “Sarah Palin Suggests Coin 
Conspiracy.” 
3 In an interview in July 2009, McCaughey was quoted as saying that Medicare will now have a “required 
counseling session that will tell [people] how to end their life sooner, how to decline nutrition, how to 
decline being hydrated, how to go in to hospice care.” Nyhan, “Why The ‘Death Panel’ Myth Won’t Die,” 
10.  
4 Belluck, “Coverage for End-of-Life Talks Gaining Ground.” 
5 Palin, “Obama and the Bureaucratization of Health Care.” 
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In Palin’s view, there appeared a conflict between the Council’s task to control 
costs with the role of government to protect and provide for its people. To Palin – and her 
many supporters – death panels proved that the ideological goal of reform (and ‘big’ 
government, more generally) was to decrease financial cost no matter the human cost. It 
was, in essence, not to reform care, but to remove those who needed it most.  
Palin’s charges were ultimately debunked by those across the political spectrum. 
However, the idea became a lightening rod for criticism of the Affordable Care Act 
(ACA) and shifted the conversation from what reform could achieve to how it signaled 
heartless cost cutting and government overreach.6 Indeed, a Pew study in late August of 
2009 found that 86% of Americans reported that they had heard the legislation “includes 
the creation of so called ‘death panels’ or government organizations that will make 
decisions about who will and will not receive health care services when they are critically 
ill,” and of those, 30% believed it was true and 20% did not know.7 Regardless of its 
eventual discrediting, Palin’s “death panels” helped drive a wave of opposition against 
reform efforts, ultimately forcing the Obama administration to withdraw the provision 
from the ACA’s final language.8 
The story of Sarah Palin’s “death panels” begins this paper because it captures the 
toxicity surrounding the ACA and its herculean task of reform, as well as more generally 
the damaging mythmaking that too often shapes policy decisions. It also speaks to the 
                                                
6 Belluck, “Coverage for End-of-Life Talks Gaining Ground.”; Weiner, “Sarah Palin Suggests Coin 
Conspiracy.” 
7 Nyhan, “Why The ‘Death Panel’ Myth Won’t Die,” 12.  
8 Belluck, “Coverage for End-of-Life Talks Gaining Ground.”; “10 FAQs: Medicare’s Role in End-of-Life 
Care.” 
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visceral discomfort that remains around discussions of death and the care we provide at 
end of life. In addition to the personal discomfort death may cause, resistance is even 
greater to the idea that someone else – let alone government – may play a role in our 
decision making. It is not surprising that supporters of Palin seized on the proposal as the 
purest sign of government overreach, but death reaches across the aisle and we are each 
of us confronted with the question of what good care and the right decisions will look like 
for us at end of life. Indeed, the breadth and ferocity of the response to “death panels” 
speaks to the emotion that is shared when we consider our lives at its close. 
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Looking Back at End of Life 
 
The resistance to discussing end of life is rooted, in no small part, in the 
development of end-of-life care. Prior to the technological advancements of the 20th 
century, death was common and occurred largely at home: either from death in childbirth 
or from diseases like tuberculosis, most families knew death and in its commonality it 
was neither taboo nor hidden from the community. In fact, “the collective reaction was to 
keep the dying person involved in everyday life until the end.”9 In the beginning decades 
of the 20th century, however, as medical treatments increased and hospital technology 
became more advanced, “the beginning of the lie” was born: death was no longer 
something you had to accept, but something you could fight. Individuals who would 
previously have been in the community, made comfortable while dying surrounded by 
friends and family (and friends and family, in turn, made more comfortable with dying), 
were now removed from the communal space. Sick individuals were moved into 
hospitals and other such care facilities, and the communities they left behind began to 
lose touch with the experience.10  
While “it is hard to imagine that we will ever return to the public interaction with 
death typical of past centuries,” models of care have since been developed which seek to 
return the dying to their communities – the primary of which being hospice.11 Though 
hospice did not enter the mainstream until the later part of the 20th century, its roots are in 
                                                
9 Niethammer, Speaking Honestly, 35. 
10 Ibid, 36.  
11 Ibid, 37.  
 8 
fact medieval.12 The word hospice derives from the Latin word ‘hospes,’ which refers to 
a traveling guest or traveler’s host. Hospice homes were first established in the 11th 
century, and were managed by religious orders to provide care for dying travelers and 
crusaders.13 Though hospices came and went in parallel with the orders who ran them, 
their more formal establishment did not occur until the late 19th century with the founding 
of St. Joseph’s Hospice in London, which is credited with birthing the modern hospice 
concept.14 Some decades later, Dame Cicely Saunders, a British nurse and social worker, 
began volunteering at another London hospice, St. Luke’s Home for the Dying Poor. Her 
work there inspired her to pursue a medical degree with a focus on palliative care.15 
Dame Saunders ultimately developed the core concepts of hospice care that include: “1) 
the concept of ‘total pain,’ including physical, spiritual, and psychological discomfort; 2) 
the proper use of opioids for patients with physical pain; and 3) attention to the need of 
family members and friends who provide care for the dying.”16 These central tenets 
describe a holistic perspective of end-of-life care that supports the entire individual, and 
remains the cornerstone of hospice and palliative practice today.  
It was not until the mid-1960s that a series of events drew attention in the United 
States towards the care at end of life. In 1963 Dame Saunders was invited to lecture at 
Yale University about her work, followed in 1969 by the publication of On Death and 
                                                
12 Pyenson et al., “Medicare Cost in Matched Hospice and Non-Hospice Cohorts,” 201.; Morden et al., 
“End-of-life Care for Medicare Beneficiaries,” 793. 
13 Lutz, “The History of Hospice and Palliative Care,” 305; Hashe, “Being There for Those at End-of-
Life.” 
14 Lutz, “The History of Hospice and Palliative Care,” 305.  
15 Lutz, “The History of Hospice and Palliative Care,” 305.; “Hospice Background.”  
16 Ibid. 
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Dying by the famed Swiss-American psychiatrist, Elizabeth Kubler-Ross. On Death and 
Dying introduced the concept of the five stages of grief that patients experience when 
dying, and it advocated for the importance of home care and the voice of the individual in 
their care.17 The topic received further attention when Kubler-Ross testified before the 
Senate Special Committee on Aging, saying:  
We live in a very particular death-denying society. We isolate both the 
dying and the old, and it serves a purpose. They are reminders of our own 
mortality. We should not institutionalize people. We can give families more help 
with home care and visiting nurses, giving the families and the patients the 
spiritual, emotional, and financial help in order to facilitate the final care at 
home.18 
 
Kubler-Ross’ words spoke to the historical movement of death from home to 
hospital, taking with it our understanding of, and comfort with, care for those at end of 
life. Rather than institutionalizing them – moving them out of our sight, largely for our 
own comfort – Kubler-Ross called on the community to think about the holistic wellness 
of the dying and how we can better honor them. Inspired by her work and the leadership 
of Dame Saunders, and further promoted by the national interest in cancer that was 
gaining speed around the same time, the United States’ first hospice was opened in 
1973.19 
                                                
17 Lutz, “The History of Hospice and Palliative Care,” 305; Hashe, “Being There for Those at End-of-
Life.”; “Hospice Background.” 
18 “Hospice Background.” 
19 Jennings, Ryndes, D’Onofrio, and Baily, The Hastings Center, 6.  
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Hospice and Palliative Care 
One of the biggest barriers to support of hospice and palliative care is the 
persistent belief that they operate solely in the business of death and dying. A lack of 
understanding about the spectrum of services that end-of-life care provides keeps many 
from attaining the higher quality, and even quantity, of life they seek for themselves or 
their loved ones.  
Hospice is a model of care provided to those with an advanced, terminal illness, 
commonly with a prognosis of six months or less to live. Hospice utilizes supportive – 
not curative – interventions to ensure quality of life, psychosocial and emotional support, 
and pain and symptom management. Hospice services include: nursing care, personal 
assistance with daily living, rehabilitation, counseling, dietary support, prescription 
assistance, and respite and other family services (among many others).20 Provided by an 
interdisciplinary team of doctors, nurses, social workers, specialists, and case managers, 
the hospice model relies on healthcare teams working together to support the “whole 
person,” which includes their family and community.21  
Palliative care likewise focuses on symptom management and quality of life; 
however, patients who are ill can access palliative services without a terminal diagnosis 
                                                
20 Huskamp et al., “Variation in Patients’ Hospice Costs,” 234.; Nakhoda, “End-of-life Care and the 
Medicare Hospice Benefit,” 25. 
21 Jennings, Ryndes, D’Onofrio, and Baily, The Hastings Center, 6.; Nakhoda, “End-of-life Care and the 
Medicare Hospice Benefit,” 25. 
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and can use it alongside curative interventions.22 Palliative “cover[s] all forms of the 
prevention and treatment of suffering,” where hospice focuses more on the final stages of 
life.23 Palliative care was developed as an outgrowth of hospice care, utilizing an 
interdisciplinary care team to meet the gaps in hospice by focusing on patients who, 
though not actively dying, suffer from a chronic or complex illness that may result in 
burdensome symptoms.24 While hospice is provided outside the hospital setting, 
palliative care is today integrated with inpatient services at most major hospitals. True to 
the teachings of Dame Saunders and the faith-based leaders before her, both hospice and 
palliative care are deeply informed by the ethics of compassion, dignity and service.25  
Though in its first decades of practice in the United States, hospice predominantly 
served white, middle and upper class patients, end-of-life care has grown to include 
palliative services and together they serve a broader range of patients and diagnoses.26 
Currently in the United States, there are 2.5 million deaths each year, of which 50% occur 
in a hospital or care setting, and 38% of those dying from ‘anticipated death’ received 
hospice.27 Use of hospice has continued to grow, with 496,000 enrollees in 1997 growing 
to over 1.6 million in 2012. While cancer remains the primary diagnosis for patients on 
hospice (44%), improvements in cancer care and increasing knowledge of other chronic 
                                                
22 Jennings, Ryndes, D’Onofrio, and Baily, The Hastings Center, 7.; Himelstein, Hilden, Boldt, and 
Weissman, “Pediatric Palliative Care,” 1752.; Hartjes, “Making the Case for Palliative Care,” 291. 
23 Ibid.  
24 Himelstein, Hilden, Boldt, and Weissman, “Pediatric Palliative Care,” 1752. 
25 Jennings, Ryndes, D’Onofrio, and Baily, The Hastings Center, 6. 
26 Ibid.  
27 Ibid, 11. 
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and complex illnesses such as Alzheimer’s continue to change the demographics of 
hospice use.28 
The benefits of end-of-life care to patients and caregivers are well documented in 
research. A wide range of studies show how hospice and palliative care help patients 
avoid invasive interventions at end of life which, however much they may extend life, do 
little to increase its quality. Gozalo et al. found that Medicare beneficiaries on hospice 
had a larger reduction in aggressive end of life interventions and a decreased rate of 
intensive care unit (ICU) admissions in the last thirty days of life, and experienced other 
positive outcomes like decreases in feeding tube insertions and “burdensome transitions” 
between care facilities.29 Obermeyer et al. identified “statistically significant” differences 
between hospice users and those without, finding that those without hospice had more 
hospitalizations for acute conditions and medical comorbidities, and had higher use of the 
ICU and other invasive procedures.30 Overall, researchers have found that patients 
receiving end-of-life care have fewer physical symptoms, improved mood, and a more 
accurate understanding of their prognosis.31 For families, hospice and palliative care have 
                                                
28 American Society of Clinical Oncology, “The Debate in Hospice Care,” 154.; “Hospice Care in 
America.” 
29 ICU admissions reflect poor symptom management and high pain, which are markers of poor quality 
care and low satisfaction at end of life (which palliative and hospice care are demonstrated to help 
ameliorate). Gozalo et al., “Changes in Medicare Costs With The Growth of Hospice Care in Nursing 
Homes,” 1829. 
30 Obermeyer, et al., “Association Between the Medicare Hospice Benefit and Health Care Utilization,” 
1893.  
31 Kang et al., “Integration of Palliative Care,” 320.; Hartjes, “Making the Case for Palliative Care,” 209. 
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also “been shown to reduce both the incidence of aggressive intervention and the 
subsequent psychological stress among surviving family members.”32 
While those unfamiliar with end-of-life care may associate it with death and 
dying, building evidence shows that it can, in fact, even extend life as individuals forgo 
the toxicity and intensity of interventions in favor of focusing on quality of life and 
building psychosocial supports around them.33 Among many studies highlighting this 
phenomenon, a 2007 report from the Journal of Pain and Symptom Management found 
that hospice patients lived 29 days longer than their non-hospice counterparts. In another 
study from 2010 from the New England Journal of Medicine, it found that patients with 
non-small-cell lung cancer in fact lived longer with hospice care.34  
For hospital administrators and payors there are substantial benefits as well. By 
enrolling patients in supportive end-of-life care, hospitals find significant savings from 
patients’ overall shortened length of stay and fewer admissions to the ICU, in addition to 
decreased “bounce back” admissions (when the patient returns within 30 days, for which 
many hospitals are penalized under the ACA’s pay-for-performance metrics).35 One 
study found that hospice saved payors $700 per day per bed by keeping patients out of 
critical care beds. Savings to patients were also generated from averted co-pays from 
forgoing unnecessary physician office visits.36 In an early meta-analysis of healthcare 
                                                
32 Wessman, Sona and Schallom, “Improving Caregivers’ Perceptions,” 2.; Hartjes, “Making the Case for 
Palliative Care,” 209. 
33 Pyenson et al., “Medicare Cost in Matched Hospice and Non-Hospice Cohorts,” 201.; Morden et al., 
“End-of-life Care for Medicare Beneficiaries,” 793.  
34 American Society of Clinical Oncology, “The Debate in Hospice Care,” 153.  
35 Passik et al., “Is There a Model for Demonstrating a Beneficial Financial Impact,” 420.   
36 Edens, Harvey and Gilden, “Developing and Financing a Palliative Care Program” 381. 
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savings from 1996, it found that hospice saved up to 40% of healthcare costs during the 
patient’s last month of life, and 17% of those in the last six months. These findings were 
echoed over a decade later, in a 2007 study that found reduction in Medicare costs during 
the last year of beneficiaries’ lives of $2,309 per hospice enrollee.37  
End-of-life care supports decreased interventions; as such, it does not generate 
revenue and is therefore often difficult to sell to hospital administrators.38 However, by 
facilitating care diversion it helps people stop unnecessary, expensive interventions that 
hospitals then must meet the cost of providing.39 Despite the substantial cost savings, 
Medicare has also been slow to fully support integrating hospice and palliative care into 
the medical mainstream. By most estimates, approximately 25% of Medicare spending is 
on the last year of beneficiaries’ lives; however, only 1% of the Medicare budget is 
allotted for hospice services. This, too, despite studies such as one from 1999, which 
found that for every $1 spent on hospice, Medicare saved $1.52.40 Building a body of 
evidence on the positive impacts of end-of-life care, therefore, is essential for the 
promotion of hospice and palliative care.  
  
                                                
37 American Society of Clinical Oncology, “The Debate in Hospice Care,” 154. 
38 Von Gunten, “Financing Palliative Care,” 780. 
39 Passik et al., “Is There a Model for Demonstrating a Beneficial Financial Impact,” 420.   
40 Nakhoda, “End-of-life Care and the Medicare Hospice Benefit,” 25.; Gozalo et al., “Changes in 
Medicare Costs With The Growth of Hospice Care in Nursing Homes,” 1824.  
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The Culture of Care 
Despite the foundational work of pioneers like Saunders and Kubler-Ross, and the 
increasing body of research that speaks to its wide-ranging benefits as well as cost 
savings, the acceptance of hospice and palliative care into the mainstream has been slow. 
This is due in part to the culture of medicine and technology that resists doing anything 
less than what is possible, the culture of physician authority that has contributed to 
patients’ deference to these tendencies towards intervention, and the cultural aversion to 
death in general that effectively postpones discussions regarding it.  
The roots of physician authority are as ancient as medicine itself: in 129 AD, the 
Greek physician, Galen, was quoted as saying, “the patient’s trust is indispensable for the 
healing process.”41 Physicians were, and for most of modern history have continued to 
be, considered of a higher professional class and therefore seldom challenged. It was not 
until World War II that more open examination of the physician-patient relationship 
began, as atrocities committed by physicians in concentration camps directly challenged 
the notion of their unquestionable authority. These inquiries continued in the United 
States as reports of the sterilization and medical testing of epileptics, the mentally ill, and 
other stigmatized communities came forward.42 This period, though painful, allowed for 
the emergence of the autonomous patient who had more decision-making power. In his 
book on communicating with dying children, the German writer Dr. Dietrich Niethammer 
refers to this period as a shift in medical culture from ethics based on responsibility 
                                                
41 Niethammer, Speaking Honestly, 42. 
42 Ibid, 43.  
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(doing what you think is best for the patient), to a contract-based ethics (doing what the 
patient has agreed to do).43 This allows for a relationship built on trust, where the patient 
may choose to follow the physician’s advice not out of deference, but free will.  
The deference to physician authority has long shaped individuals’ relationships 
with their illness and options for care. So, too, has physicians’ own inability to face the 
death of their patients and the limits of medicine. In the days before modern medicine, 
physicians avoided discussing death from an acknowledgement that in many cases, there 
was little more they could do than allow the patient hope. In the words of the 19th century 
German doctor Christoph Wilhelm Hufeland, “He who names death, brings death.”44 In 
the modern age, physicians have been able to avoid discussing death by focusing instead 
on the curative capacities of technology. The consequence of technological progress, 
however, is that no matter the lives it has saved, “it has had the unintended consequence 
of offering false hope to [patients] that death can always be averted.”45 Death is seen 
“more as a therapeutic misadventure than as a natural process resulting from a disease,” 
and “recognition that death is inevitable often lags behind the reality of the medical 
condition, leading to a treatment approach that is inappropriately aggressive.”46  
Data on the interventions that the critically ill and actively dying undergo speak to 
the extent to which the culture of intervention drives care: in 1996, a study on Medicare 
beneficiaries dying from cancer found that 22% of patients received a new round of 
                                                
43 Niethammer, Speaking Honestly, 46. 
44 Ibid, 101.  
45 Himelstein, Hilden, Boldt, and Weissman, “Pediatric Palliative Care,” 1757. 
46 Ibid. 
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chemotherapy in their last month of life, and that from 1993 to 1996 treatment within the 
last two weeks of their life went up by 5%, with similar rates found in those whose cancer 
was already deemed unresponsive.47 In a more recent study on ICU admissions at end of 
life by Rady and Johnson, over 70% received aggressive therapy including life support 
when their short-term survival rate was less than 50%.48 This study built on the findings 
of an earlier one that found that even when patients expressly desired comfort care 
(symptom management only), physicians still initiated aggressive therapies.49 As 
described in the Rady and Johnson study, “the disparity between the type of therapy 
offered by physicians and the care consistent with patient prognoses has been recognized 
as a major obstacle to the quality of end-of-life care.”50 
Considering the centrality of intervention to medicine, it is no surprise that 
hospice and palliative care have been slow to gain traction. As described by the American 
Society of Clinical Oncology (ASCO), “paradoxically, the very advances in treatment 
that have enhanced cancer care and survival have created perhaps the most important 
barrier to the effective use of hospice.”51 For many physicians, hospice and palliative care 
are viewed as “giving up” on potential life-extending treatments, a threat to their curative 
powers and those of technology. The little training that medical professionals receive on 
leading end-of-life care discussions has worsened this resistance. For many, it is also 
simply too personally difficult to talk to their patients and families about dying when the 
                                                
47 Matsuyama, Reddy and Smith, “Why Do Patients Choose Chemotherapy,” 3490. 
48 Rady and Johnson, “Admission to Intensive Care Unit,” 708. 
49 Ibid, 706. 
50 Ibid, 708. 
51 American Society of Clinical Oncology, “The Debate in Hospice Care,” 154. 
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care relationship has so far been based in curative hopes.52 A study by Steinhauser et al. 
on the factors important to patients at end of life found that, “one of the challenges of 
comprehensive end-of-life care [is] attending to aspects of care that are not intuitively 
important to clinicians but are critical to patients and their families.”53 This speaks to 
findings of other studies that have identified patient priorities that do not match their 
physician’s: one study found that patients ranked mental awareness highly whereas 
doctors were more willing to sacrifice lucidity for pain suppression.54 Steinhauser et al. 
continue: “as our cultural lexicon of death and dying expands, further research is needed 
to define both the common ground and areas for negotiation as participants gather to 
construct quality at the end of life. A challenge to medicine is to design flexible care 
systems that permit a variety of expressions of a good death.”55 Supporting physicians to 
be better participants in this discussion is necessary to support better end-of-life care.  
It bears noting that while physician resistance to discussing death is a substantial 
barrier to timely discussions of end-of-life care, patients can, and often do, contribute to 
the extension of interventions past the point of effectiveness. The principle that 
“medicine, and more broadly science, delivers the goods,” is driven in large part by the 
comfort that certainty brings.56 When faced with illness, patients seek hope; tests and 
procedures help alleviate the anxieties of a poor or uncertain prognosis. As described by 
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Allan Detsky, “although many patients prefer not to ‘know’ or ‘try’ [when death is near], 
the majority of those who seek health care prefer active strategies…. an extra test or two, 
‘just to be sure,’ is often preferred to possibly missing something.”57 These impulses are 
furthered by family members, who may fear the feeling that they “didn’t do enough” to 
help their ill loved one and therefore encourage further treatment.  
The culture of intervention at end of life is also supported by medical and legal 
policies in the healthcare system more generally that incentivize “defensive medicine.”58 
Defensive medicine – doing more than what is necessary for the patient in order to 
protect the physician – is driven by physicians’ fears of malpractice, which is substantial: 
in 2008, malpractice costs were estimated at $55 billion per year, accounting for 
approximately 2.5% of annual overall health care spending.59 The fee-for-service 
reimbursement model further promotes defensive medicine as it incentivizes providers 
for the number of tests and procedures they order. While the development of new 
technologies has brought promise to patients and their providers, advances “create 
opportunities for error in diagnosis and treatment,” as studies have shown that liability 
claims increase when new technologies are introduced (though level off over time).60 The 
technologies that patients put their hopes in further drive the costs of their care, though 
the question remains the extent to which they improve their outcomes. Indeed, studies 
show that of the many advances which seek to improve care, physician’s open and honest 
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communication with their patients does the most to satisfy patients and decrease the 
chance of malpractice suits.61 
For end-of-life care specifically, the pressure to treat has been furthered even 
more by legal decisions that have sought to protect the critically ill from negligent 
treatment. The “Baby Doe” regulations of the mid-1980s required treatment of potentially 
handicapped infants, while an amendment to the Child Abuse and Protection Act of 1984 
broadened the scope of what counts as “medical neglect” to include the withholding of 
medically indicated treatment for infants with life-threating conditions.62 Though targeted 
at pediatrics and the protection of medically fragile children, these kinds of decisions 
have drawn a connection between withdrawal of care and neglect or mistreatment. They 
communicate to the broader care community that more than fewer interventions is the 
right path. 
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Medicare and Hospice  
 
Since the first hospice opened in 1973, the care we provide those near the end of 
life has come a long way. While deep resistance and discomfort remains, for the 
individuals who face it as well as the providers who face the limits of what they can do to 
help, we are far from that “death-denying society” that Kubler-Ross identified. The 
integration of end-of-life care has been profoundly furthered by policies designed to 
support it, the primary being the Medicare Hospice Benefit (MHB), which was 
established in 1983 to provide reimbursement for hospice services. Together with quality 
measurement, which seeks to ensure accountability for the services reimbursed, the MHB 
is a central support for end-of-life care and has given access to care for countless 
individuals in need.63 It is an essential benefit, but also flawed. Considering the extent to 
which reimbursement shapes care delivery, and the growing population of beneficiaries 
who will need it, analysis of its shortcomings is crucial to support its improvement and 
ensure that it meets the needs of its beneficiaries.  
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A GROWING INDUSTRY 
 
In 2015, Medicare spent over $615 billion on its beneficiaries’ care, 25% of 
which on their last year of life, and of that, over 75% on the last month.64 This trend 
speaks to the high utilization of interventional care at end of life, which is only expected 
to rise as the coming “silver tsunami” of the country’s aging population brings longer 
lifespans, as well as higher, continued care costs.65 Indeed, 9 out of 10 Medicare 
beneficiaries have one or more chronic conditions (including cancer, organ system 
failure, dementia or stroke), and the incidence of cancer is expected to rise 45% in the 
next twenty years.66 Though people are living longer lives, they are not necessarily 
healthier ones, and the costs of their care – particularly at end of life – are profound 
(estimated to reach $346 billion by 2040).67 Reflecting this growth, Medicare 
expenditures on hospice increased from $2.9 billion in 2000 to over $18 billion today, 
while the number of hospices in operation has grown from 10 at the time of the MHB’s 
founding, to over 5,800 by 2013.68  
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THE MEDICARE HOSPICE BENEFIT 
 
The creation of the MHB in 1983 made it possible for those near the end of their 
lives to access crucial support by providing reimbursement for hospice services and 
effectively expanding the number of providers in operation. However, the MHB has 
largely remained unchanged since its founding, and in recent years has come under 
criticism for its structure which, despite the benefits, has restricted access for many 
patients and incentivized the wrong kind of care by providers. The primary criticisms of 
the MHB stem from its eligibility requirements for patients. In order to be eligible the 
patient must: 1) be eligible for Part A (hospital services), 2) have a prognosis of six 
months or less to live, 3) sign a statement forgoing all curative treatment under their usual 
Part A coverage, and 4) receive hospice from a Medicare approved provider.69 The 
requirement for a six-month prognosis and the forgoing of curative treatment, in 
particular, are cited as the major reasons why individuals enter hospice care late.70  
First, the requirement for a six-month prognosis fails to appreciate the changing 
demographics of those in need of hospice. While cancer has historically been the primary 
diagnosis, today there are many in need of hospice with diseases such as heart disease, 
Alzheimer’s, or pulmonary failure that are terminal but do not follow as clear a disease 
trajectory.71 The inaccuracy of prognoses for these diseases is often made worse by 
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overestimation by physicians, rooted in their lack of training with end-of-life discussions 
and their own unwillingness to begin such conversations when the efficacy of curative 
interventions begins to decline.72 As found in the study by Rady and Johnson, “when 
physicians’ estimates of life expectancy were based solely on disease severity, survival 
probabilities were commonly overestimated and misled patients when asked about 
preferences for the appropriate care in certain chronic diseases.” 73  
Second, the requirement that patients forgo curative treatment likewise fails to 
appreciate the individual needs of patients and their specific disease trajectory. The 
requirement, intended to keep patients from ‘double dipping’ in their Part A benefits, in 
effect reinforces the idea of end-of-life care as “giving up.”74 It creates a false choice 
between curing a disease (life) and withdrawing care (death), and fails to appreciate the 
spectrum of medical interventions and palliative treatments available to patients. 
Concurrent care, on the other hand, allows the patient to receive “curative care to 
eradicate disease or normalize the underlying health condition, while simultaneously 
receiving hospice care for physical symptoms and psychosocial needs at end of life.”75 
Despite the substantial body of evidence that proves the benefits of hospice care, this 
provision in most cases pushes patients to choose continued interventions, despite the 
delay it ultimately causes in accessing hospice’s more supportive therapies.76 
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For providers, the MHB is also flawed. The MHB reimburses on a flat, per diem 
rate according to four payment categories: routine home care (RHC); continuous home 
care (CHC); general inpatient care (GIC); and inpatient respite care (IRC).77 Each are 
paid at different rates, which are set on a regional basis, adjusted for the specific costs of 
care (e.g. labor), and increased according to increases in the prices for the hospital market 
basket (described as a “fixed-weight index”).78 The vast majority of hospice claims 
(96%) are submitted for RHC: in 2008 the rate was $135.11, by 2015 it had increased to 
$159.79  
Several issues with the per diem payment structure have been well documented. 
First and foremost, the per diem rate is paid to hospice providers for each day of the 
patient’s enrollment, regardless of the level of care required or its costs. A study by 
Huskamp et al. on hospice cost variation found that the largest driver of cost is the length 
of stay, with care costs highest at the beginning (when staff is getting acquainted with the 
patient’s needs), and at the end (as more intensive palliative care is required at time of 
death).80 No matter the variation, providers are paid the same amount for each day of 
care. The per diem rate also fails to take into account the costs of palliative interventions, 
which are often very high. For example, palliative chemotherapy – primarily used for 
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symptom reduction – is estimated at $30,000 per treatment.81 At $159 per day, the 
MHB’s reimbursement goes little of the way to cover these costs, and instead has the 
effect of incentivizing providers to avoid higher cost patients.82 
Despite its poor reimbursement, the MHB remains the lifeblood of the hospice 
industry: 75% of reimbursement for hospice services comes from the MHB, while 12% 
comes from private insurance and 7% from Medicaid and donations.83 Hospice providers, 
therefore, must find ways to make ends meet largely with what little the MHB provides. 
Unlike their non-profit counterparts who also receive support from foundations and 
grants, for-profit providers operate on razor thin margins. Research has identified 
distorted enrollment patterns between for-profit and non-profit providers, as for-profits 
more frequently target patients whose prognoses are more uncertain and will likely result 
in a longer length of stay.84 Patients with lower day-to-day care needs, but longer overall 
anticipated lengths of stay, represent the “best” way for providers to recoup their costs.85  
This trend speaks to a central inconsistency of the MHB: while it penalizes 
providers for keeping patients past their prognoses, the low per diem payment incentives 
longer lengths of stay as hospice providers need to balance the costs of providing care to 
                                                
81 American Society of Clinical Oncology, “The Debate in Hospice Care,” 155.  
82 Nakhoda, “End-of-life Care and the Medicare Hospice Benefit,” 26.  
83 Jennings, Ryndes, D’Onofrio, and Baily, The Hastings Center, 27.; Nakhoda, “End-of-life Care and the 
Medicare Hospice Benefit,” 24. 
84 Thompson, Carlson and Bradley, “US Hospice Industry,” 1287.  




those who enter hospice late and require acute care.86 The reimbursement structure is 
based on the logical assumption that hospice is for people at the very end of life and they 
die as presumed by their prognosis (as if they do not, then they should not be on hospice). 
However, this is often inconsistent with the reality of the provider where the schedule of 
payments often does not match the patients’ actual disease trajectories, or their costs.87 
In addition to selective enrollment, research also found that for-profits offer a 
more narrow range of services: they are less likely to offer palliative radiation (an 
effective, though costly, tool for symptom management) as well as bereavement and 
family support services, and have lower proportions of higher qualified staff (e.g. 
registered nurses or social workers).88 Though in pursuit of the care needs of the 
exploding population of elders, for-profits struggle to operate on low reimbursement and 
the downward pressure to cut costs is ultimately shouldered by patients.89  
While disagreement exists in the research community as to the exact reasons for 
differences between for- and non-profit providers, there have been a sufficient number of 
studies pointing to the disproportionate growth of for-profit hospices (and subsequent 
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inquiries into their enrollment practices and quality of care) to inspire the Medicare 
Payment Advisory Commission (MedPAC) to reexamine the MHB with an eye towards 
how it influences the demographics of hospice providers and the care they provide.90  
THE BEGINNING OF REFORM 
 
Under the leadership of MedPAC, researchers, advocates, and policymakers have 
begun analyzing the full extent of the MHB’s influences on end-of-life care. As a first 
step, MedPAC, along with the HHS Office of Inspector General, highlighted the potential 
for hospice providers to use selective enrollment as a means to maximize financial gain, 
going so far as to say that the MHB may in effect “distort patterns of enrollment and 
use.”91 Given their findings that the incentives are misaligned with quality care and 
timely enrollment, improvement should “try to project backward both to improve the 
local health care system’s ability to deliver seamless and better care, as well as to 
introduce hospice care earlier so as to potentially enjoy the benefit of greater numbers of 
people admitted to and followed in hospice for longer than 30 days.”92 This would allow 
providers to have a greater number of patients whose care is less short, acute, and costly, 
so that other patients do not have to carry the disproportionate weight of their care.  
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Consistent with this goal, CMS introduced its own solution. In 2015 it issued a 
hospice payment rule for fiscal year 2016, “the first significant changes to hospice 
payment methodology since the Medicare benefit went into effect in 1983.”93 While the 
core eligibility requirements remain unchanged, the proposed revisions significantly alter 
the payment mechanism by creating “service intensity add-on” (SIA) payments, which 
provide higher reimbursement at the beginning and end of an enrollee’s care for face-to-
face services provided by a registered nurse or social worker. These payments better 
reflect the reality of providing hospice care, including the periods of higher intensity and 
cost. SIA payments will be made on top of the usual per diem rate and can be charged up 
to four hours per day.94 SIA payments in effect make longer lengths of stay no longer as 
necessary, and shorter lengths of stay no longer as disproportionately costly. In addition 
to the SIA, CMS’ rule created differential payment of two separate rates for routine home 
care: care for days one through sixty, and care for days sixty and after, again reflecting 
that care needs are not uniform throughout an enrollee’s hospice stay.95  
Another critical element of CMS’ rule is the authorization of payment for doctors’ 
consultations with patients about end-of-life care options (advance care planning). 
Originally waylaid by Sarah Palin’s “death panels” controversy and the general toxicity 
surrounding health care reform, advance care planning regained ground with legislative 
support in both the Senate (the Care Planning Act of 2015) and House (Personalize Your 
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Care Act of 2013).96 The CMS rule will help individuals learn about their care options, 
determine which best fit their wishes, and share those wishes with family, friends, and 
care providers. For these consultations, Medicare will pay $86 for the first 30 minutes of 
the session in a doctor’s office, $80 in a hospital, and $75 for every additional 30 
minutes. The new billing codes will be in the physician fee schedule, and the consultation 
happens “at the discretion of the beneficiary” – at their specific request – to allay fears of 
bureaucrats forcing unwanted discussions or choices.97 
Despite these important first steps at reform, CMS’ failure to revise the eligibility 
requirements for patients to receive hospice remains a substantial hurdle. However, early 
experimentation with revised eligibility is under way. In 2016, the Medicare Care Choice 
Model begins: a three-year, budget neutral demonstration project made possible under the 
ACA to assess if patients who remain eligible for both curative and hospice interventions 
experience improved quality of care, satisfaction, and effectiveness of medical 
interventions. The program will be piloted in 140 hospices for hospice-eligible patients. 
Hospice providers will be reimbursed on a monthly rate, between $200 and $400, which 
will be phased in over the next two years. The program is expected to reach at least 
150,000 eligible Medicare patients.98  
This model builds off the ACA’s provision on concurrent care for children, which 
requires state Medicaid/CHP programs to allow children under the age of 21 with a six-
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month prognosis to receive hospice and curative care simultaneously.99 While neither the 
Medicare Care Choice Model nor the children’s program on which it is based revise the 
six-month prognosis requirement, early findings show that concurrent care is, indeed, a 
positive change. Reported benefits of concurrent care for children include: improved 
patient-physician communication, easier transitions between care providers, improved 
patient and family satisfaction, and decreased financial burden on families.100 These 
findings encourage support for concurrent care and its expanded provision to adults.  
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Quality Measurement  
 
End-of-life care developed from a foundation of religious and ethical obligations 
to the critically ill and dying. The MHB represented the United States’ acceptance of end-
of-life care as a worthwhile modality, and despite its shortcomings, it has continued to 
provide access to care for many beneficiaries. Recent reforms have continued this 
commitment through efforts to improve and expand end-of-life care services. Fulfilling 
this promise, however, requires the mechanisms for assuring quality. Quality 
measurement is critical for this process.  
In the ACA environment, which seeks to replace fee-for-service with pay-for-
performance, quality measurement is closely tied to reimbursement and as such, is an 
essential piece of the structure that supports end-of-life care. Measurement of end-of-life 
care is complicated, however, by the very individual nature of death itself. Research on 
what patients and their families want at end of life often centers on this question of what 
makes “a good death,” and research findings critically inform the measures used to judge 
its success. With consideration of the holistic, person-centered model that is hospice care, 
it is all the more important to ensure quality measurement reflects what patients, not 
politics, want at end of life, to ensure the care provided – and reimbursed – is the care 
patients and their families want and need.  





Trying to define what makes a “good death” is a difficult, if not impossible, task, 
as death and dying mean very different things to different people and are impacted by 
cultural, social, and religious norms. As much as we want, “we cannot suppress the 
question of what counts as a ‘good death’ (or perhaps more accurately, ‘dying well’) and 
what counts as good care near the end of life.101 Categories of care provide ways to 
organize the range of patient preferences collected in research, and reflect the different 
dimensions of holistic care. The first category – physical – captures the importance of 
having a safe and clean environment in which to be ill and ultimately die, sufficient food 
and nutrition, good pain control and symptom management, and attention to personal 
care. The emotional category highlights the preservation of dignity and self-worth, 
respect for patient wishes, information on emotional changes and the availability of 
counseling, advance planning and spiritual guidance. The social category highlights the 
importance of companionship, narration of life, resolving relationships, and settling 
unfinished business.102  
Research on experiences at end of life reveals trends within each of the three 
categories, which together can suggest a common understanding of what makes “a good 
death.” Within the category of emotion, fear predominates. Patients frequently report 
fears about losing control – both physically (succumbing to the disease) as well as 
cognitively (no longer being mentally aware or in a position to make decisions about 
one’s care). Also common is the fear of loss of independence and dignity, a fear that the 
                                                





force of their illness will subsume them, along with their wishes.103 There is also great 
fear reported within the physical category: about not knowing what is going to happen to 
them, or how much pain they will suffer in the process of dying. There are also 
commonly reported fears of being a burden; conversely, the fear of being abandoned is 
also frequently cited.104  
 It is no surprise that when contemplating death, one is fearful. But what is clear 
from patient report is that in dying there are also opportunities to reflect and gain self-
awareness that many fail to take advantage of while in good health. Within the social 
category of care these include making meaning of the life lived and gaining a sense of 
“completion.”105 For many suffering from a terminal illness, the trajectory of their disease 
signifies that at some point they will be unable to articulate their own wishes. A common 
desire, therefore, is that the individual finds ways to remain autonomous. Ensuring 
preferences are respected and receiving empathic care are two common goals expressed 
by dying patients.106 These findings emphasize the importance of advance care planning 
so that individuals’ wishes are respected even when they can no longer articulate them; 
unfortunately, while 80% of people said they would want to talk with their doctor about 
plans for end of life, only 7% actually do.107 
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Despite Sarah Palin’s toxic mythmaking, end-of-life counseling is a deeply 
patient-centered service: enabling patients to be the directors of their own care, whether it 
be to continue aggressive interventions or withdraw care and focus on comfort and 
support. Studies show that when asked, more often than not patients voice their desire to 
stop treatments and focus instead on quality of life for the time remaining. One study 
found that patients who had end-of-life conversations had 36% lower expenses from 
decreased interventions, suggesting that when given the chance to discuss alternatives, 
many patients choose to forgo further intervention.108  
There are many community-based programs that provide advance care planning 
and support that speak directly to patient preferences, with positive results. In his study of 
a California program called Advanced Illness Management (AIM), which is modeled off 
of the Respecting Choices model, an evidence-based advanced care planning model, 
Harris Meyer identified significant barriers to entry to hospice such as fear. By providing 
warm hand-offs between providers, AIM proved effective in supporting communication 
around wishes for care and decreasing patients’ fears about hospice – not as a place to 
die, but as a means to live with quality.109 Through symptom management, care planning, 
and psychosocial support, AIM uses a patient-centered approach that responds to the 
voices of its patients.110 AIM also proves financially beneficial: among its client 
population, there was a reduction in hospitalizations and inpatient direct care costs on 
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average of $2000 per month.111 While health care savings are valuable data to build 
support for this model of care, more important is how AIM shows that end-of-life 
conversations do not force individuals into decisions against their will, but rather opens 
communication about end of life and the options for care available. In the words of 
AIM’s project manager, “we’re just doing what people ask. We are most explicitly not 
pulling the plug on Granny.”112 
QUALITY UNDER THE ACA  
 
Research has shown that end-of-life care increases patient satisfaction, improves 
outcomes, and does so at decreased cost. It is, in many ways, an exemplar of the Institute 
for Healthcare’s “Triple Aim,” the “broader system of linked goals” of improved patient 
experience, population health, and decreased cost that are the main framework for the 
ACA.113 To achieve this vision, with awareness that “our [current] healthcare system is 
unaffordable and fails to deliver consistent quality,” policy has refocused its efforts on 
quality reporting with the understanding that “we need good measures of quality 
healthcare so we can direct our limited resources where they provide the most value.”114 
To do this for hospice, the ACA created the Hospice Quality Reporting Program 
(HQRP), whose measures and the processes by which they are reported are determined 
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by CMS.115 The ACA also gave CMS the ability to change the hospice payment methods, 
though required that they be budget neutral. While cost is often the primary policy metric 
for success, “the ultimate verdict concerning hospice’s integration into the broader health 
care system will be determined by the quality of end-of-life care that patients receive.”116  
CMS ultimately developed two sets of data which hospices are required to submit: 
the Hospice Item Set (HIS) and the Consumer Assessment of Healthcare Providers and 
Systems (CAHPS) Hospice survey. Informed by the ACA’s “pay-for-performance” 
model of quality assurance, hospices are penalized by 2% in the next fiscal year for each 
year that they do not submit the required data.117 It bears noting, however, that the 
requirement currently is only “‘pay-for-reporting,’ meaning it is the act of submitting the 
data that determines compliance,” and not the quality of performance.118 While a 
performance-oriented penalty would presumably affect quality, some believe the current 
compliance test represents an “easing in” of quality reporting requirements for both the 
industry and CMS. It provides CMS data for developing future performance-based 
penalties, and allows hospice providers time to prepare for closer examination of their 
services.119  
Additionally, while CMS is required to establish procedures to make the reported 
data available to the public, as well as give hospice providers time to review data before 
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its dissemination, it has not set a date for public availability of the reported data.120 The 
reputational effects of having data shared with the public could lead some hospice 
providers to improve their services, a different kind of incentive in the absence of CMS’ 
penalties for poor performance. To that end, studies have found “strong evidence of the 
effectiveness of public reporting on quality improvement,” as “public reporting is thought 
to be a key strategy for influencing market forces and, to a lesser extent, 
professionalism.”121 However, as currently no data is disclosed, it is impossible to 
evaluate the reputational effects sharing would achieve.  
In pursuit of clarity on CMS’ intent for its hospice reporting requirements, this 
author submitted an inquiry to CMS on the intent of pay-for-reporting and the reason for 
withholding the data from the public. CMS responded that it has determined that four 
quarters of data is needed to validate the data before releasing it to the public. CMS 
writes: 
CMS recognizes that it is essential that the data made available to the 
public be meaningful and that comparing performance between hospices requires 
that measures be constructed from data collected in a standardized and uniform 
manner.  It is also critical to establish the reliability and validity of the measures 
prior to public reporting in order to demonstrate the ability of the measures to 
distinguish between the quality services provided.  To establish reliability and 
validity of the quality measures, at least four quarters of data will need to be 
analyzed.  In addition, the Affordable Care Act requires that reporting be made 
public on the CMS Website.  Providers will have an opportunity to review their 
quality data prior to public reporting.122 
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This response speaks both to the presumed “easing in” of reporting requirements 
as well as the delay in releasing collected data to the public. While it remains unclear to 
this author from CMS’ response whether it intends to shift from pay-for-reporting to pay-
for-performance after the four quarters conclude, this first step by CMS to ensure that its 
measures are validated and allow for accurate comparison is important, and will 
ultimately allow patients to be more informed consumers of their healthcare.    
Quality measurement has little effect if its findings are not used to hold those 
measured accountable, and the current penalties, though short of pay-for-performance, 
acknowledge that incentives are necessary to spur change. As Berwick, Nolan and 
Whittington write in Health Affairs, the pursuit of the Triple Aim “is not congruent with 
the current business models of any but a tiny number of US healthcare organizations.”123 
They continue: “from the viewpoint of individual actors responding to current market 
forces, pursuing the three aims at once is not in their immediate self-interest… The great 
task in policy is not to claim that stakeholders are acting irrationally, but rather to change 
what is rational for them to do.”124 This echoes the Institute of Medicine’s call in its 
report Dying in America that, “federal and regulatory action [is needed] to establish 
financial incentives for integrating medical and social services for people nearing the end 
of life.”125 When taken together with the introduction of SIA payments to better support 
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providers in their care of high needs patients, the penalization (albeit weakly) attempts to 
provide an additional financial incentive to improve behavior.  
HIS, CAHPS, AND PATIENT PREFERENCE   
 
The Hospice Item Set (HIS) is one of two surveys used by CMS for quality 
measurement of hospice services. The HIS collects patient-level data at time of admission 
(within 14 days) and at discharge or end of care (within 7 days). Unlike surveys that are 
given to patients or their caregivers, the HIS is formed from data taken from the patient’s 
medical record and is therefore more standardized.126 The data drawn from the medical 
records is used to calculate scores along seven different domains [see Appendix A for 
specific measures], endorsed by the National Quality Forum (NQF): 
1. NQF #1617: Patients Treated with an Opioid who are Given a Bowel Regimen 
2. NQF #1634: Pain Screening  
3. NQF #1637: Pain Assessment 
4. NQF #1638: Dyspnea Treatment  
5. NQF #1639: Dyspnea Screening 
6. NQF #1641: Treatment Preferences 
7. Modified NQF #1647: Beliefs/Values Addressed (if desired by the patient)127 
 
The measures used in the HIS represent  “the largest evolution in hospice quality 
monitoring,” as previous item sets were far more limited – e.g. one process and one 
structural measure – and were formed from the fourteen quality measures that NQF 
endorsed in 2012.128 [Appendix B] The HIS focuses on primary medical symptoms like 
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pain and dyspnea, or shortness of breath, with attention paid to the ethical/legal elements 
of care related to patient decision making and beliefs. 
The Consumer Assessment of Healthcare Providers and Systems (CAHPS) 
hospice survey is given post-death to the patient’s caregiver to assess the patient and 
family experience. The purpose of this survey is: 1) to provide public information about 
providers to assist future patients in the selection of their provider, 2) to help providers 
with their own quality improvement initiatives, and 3) to provide CMS with data on 
providers for their monitoring and evaluation.129 Administered by mail, telephone, and 
mail with telephone follow-up, the survey is required only for hospices with over fifty 
patients, and data is required quarterly. The CAHPS hospice survey consists of eleven 
quality measures, consisting of composite, single item, and global measures, the 
combination of which “allows consumers to quickly review the caregiver’s experience 
with hospice care.”130 [Appendix C]  
Comparing these measurement tools against the categories of patient experience 
desired at end of life reveals the extent to which CMS’ requirements ultimately support 
the provision of care patients desire. As previously stated, research on patient preference 
has highlighted common desires including: the maintenance of physical comfort (e.g. 
being kept clean, out of pain), the concern for caregivers and family (e.g. the burden of 
care, their own preparation for the patient’s death, resolving conflicts), the maintenance 
of dignity and accomplishing a sense of peace (e.g. their own sense of completion, having 
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someone to talk to about their fears and reflections), and desires regarding place and kind 
of death (e.g. having certain people present, comforts like specific food, music, or 
environment).131 [Appendix D] 
Examining the measures that the HIS and CAHPS collect show that patient 
wishes are, generally, well represented in CMS’ evaluation, both in regards to individual 
items as well as the broader categories of care. Within the emotional and physical 
categories, both the HIS and CAHPS capture important dimensions of quality end-of-life 
care as identified in research on patient preferences. In the category of physical, which 
focuses on the importance of a clean and safe environment, good personal care, and 
comprehensive symptom management, the HIS assesses for “getting help for symptoms,” 
“understanding the side effects of pain medication,” and “getting timely care.”132 The 
CAHPS similarly assesses for “pain screening and assessment” and “dyspnea screening 
and treatment.”133 In the category of emotional, both surveys capture the value of dignity 
and self-worth, respect for patient wishes, timely information provided to patient and 
family for planning purposes, as well as spiritual guidance and counseling. The HIS in 
particular assesses for many dimensions within this category: “hospice team 
communication,” “treating family members with respect,” “providing emotional 
support,” “support for religious and spiritual beliefs,” and “information continuity.”134 
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The CAHPS, while more focused on clinical symptoms (the physical category), also 
assesses “treatment preferences” and “whether beliefs/values were addressed.”135  
Despite their attention to the physical and emotional categories of care, both 
measures lack attention to the social category, which attends to the importance of 
companionship, the desire to narrate one’s life (remembering one’s accomplishments and 
reflecting on them to find completion), and resolving conflicts and unfinished business. 
These desires are as important as managing symptoms, as without their resolution they 
can contribute to angst and anxiety that contribute to a poorer overall experience.136 For 
example, advance care planning materials exist that give individuals the space not only to 
articulate their desires for care, but also to explore issues such as unresolved conflicts. 
“Five Wishes” is an easy-to-read advance directive published by Aging with Dignity, 
which includes space to write about unresolved conflicts, leave messages for those with 
whom they have lost touch, or reflect on their own lives. While opportunities for these 
reflections are more expansive in the adolescent version, “Voicing My Choices,” both 
provide more space than standard advance directives to explore these components of 
one’s social needs and speak to the importance of providing a space to do so.137   
Despite the fact that standard end-of-life assessments include screening for 
depression and anxiety, psychological stressors are most poorly represented on both HIS 
and CAHPS measures. While the CAHPS survey collects information on the level of 
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emotional support received and the extent to which concerns were listened to and 
addressed, only one question specifically identifies psychological symptoms of anxiety or 
sadness.138 This disparity is even more severe with the HIS. As Webb and Kamal write in 
their editorial, the HIS excludes psychological measures “despite the recommendations of 
the American College of Physicians clinical practice guidelines for regular assessment of 
this common symptom in palliative care and at the end of life,” which is significant as 
medical symptoms can be worsened by unmet psychological needs.139 The HIS in 
particular makes clear distinctions among physical, emotional and psychological 
symptoms, despite robust research – and the model of hospice care itself – that argues for 
their interconnectedness.  
As the study by Schenck et al. on measures of hospice and palliative care 
confirmed, there is disproportionate focus in measurement on physical domains of care to 
the detriment of other domains. They found that out of 174 measures analyzed, 47% were 
focused on physical symptoms, followed by “structure and process.”140 It bears further 
exploration, therefore, on how to better incorporate the psychosocial dimensions of end-
of-life care into hospice quality measurement, so that CMS reimbursement supports the 
provision of care that truly meets the whole spectrum of a dying patient’s needs.  
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The Medicare Hospice Benefit and the Hospice Quality Reporting Program are 
two critical supports upholding hospice: the mechanism that pays for services, opening 
access to individuals in need and supporting providers who seek to serve them, and 
measuring quality to capture clinical outcomes of individuals and assess the performance 
their providers. Both reflect honest, earnest desires to expand access and ensure quality at 
end of life, but as has been explored, both have substantial shortcomings that limit their 
ultimate effectiveness. From the belief that only by identifying what is flawed will we be 
able to improve, the following are recommendations on how to strengthen these pillars of 
the hospice infrastructure.  
MEDICARE HOSPICE BENEFIT 
 
Despite its many benefits, the criteria eligibility for the MHB ultimately delays 
entry into hospice for many patients. The primary recommendation, therefore, is to 
remove unnecessary barriers that delay entry into hospice so that the benefits to patients – 
as well as the substantial cost savings – can be more fully realized. This can be 
accomplished by revising the six-month prognosis requirement, reimbursing for 





First, expanding the six-month prognosis requirement to more closely reflect the 
disease demographics of those in need of hospice would expand access for many patients 
and promote their timelier enrollment. As has been reviewed, the benefits of hospice are 
substantial both to the individual and their families, as well as in terms of cost savings. 
Restricting individuals whose disease trajectory is more protracted to the six-month 
timeline ensures that by the time they reach the final months of their life, they will have 
missed many of the opportunities that hospice provides, and their benefits, too, will not 
be as clearly felt. This is particularly true for the growing population of patients with 
degenerative brain disorders such as Alzheimer’s, whose disease course can be 
prolonged. 
Second, the promotion of concurrent care would effectively bring end-of-life care 
further upstream in the care continuum and also promote timelier enrollment. As early 
research shows, and as has already been proven on the pediatric level, concurrent care 
improves outcomes as well as decreases costs. The longer a patient is enrolled in hospice, 
the better their outcomes and the greater their savings.141 While resistance to concurrent 
care stems from the feared costs of beneficiaries “double dipping” in their Part A 
benefits, timely enrollment actually decreases the number of ICU visits and other 
aggressive interventions that are significant drivers of healthcare spending at end of life.  
Third, the promotion of palliative care programs in hospital and outpatient care 
settings would help introduce patients, families, and their providers earlier to end-of-life 
                                                




care. As palliative care is often introduced to patients closer to diagnosis, it can provide 
the means of giving the warm handoff between providers and facilitate the transition to 
hospice (if that is the patient’s wish). As California’s AIM program showed, warm 
handoffs help ease the fears surrounding care transitions, and ensure that through 
supportive communication and assistance with advance care planning, patients’ goals for 
quality of life are paramount. 
HOSPICE QUALITY REPORTING PROGRAM 
 
The HIS and CAHPS surveys offer comprehensive assessments of hospice 
experience; however, as with the MHB, there remain opportunities for improvement. 
First and foremost, social and psychological measures should be better represented in 
both, considering the centrality of psychosocial experiences to clinical outcomes. As a 
review of both surveys found that they disproportionately focus on physical symptoms, it 
is imperative that they incorporate measures more reflective of hospice’s holistic model 
of care and in particular, the specific domains voiced by patients as those most important 
to them. Otherwise, measurement assesses for services and outcomes that may not reflect 
patient preferences, ultimately sustaining a provision of hospice that does not meet their 
needs. And though quality measurement is not yet used for performance-based penalties, 
when it is used it will be all the more important that it reflects patient preference, so that 




As an example of how measurement can more accurately reflect holistic care, in 
2013 the National Consensus Project for Quality Palliative Care updated its clinical 
practice guidelines for palliative care, in acknowledgement of the importance of 
incorporating psychosocial factors in an assessment of care.142 It includes: 1) structure 
and process of care; 2) physical aspect of care; 3) psychological and psychiatric aspects; 
4) social aspects; 5) spiritual, religious, and existential aspects of care; 6) cultural aspects 
of care; 7) care of the patient at end of life; and 8) ethical and legal aspects.143 Over half 
of its domains highlight elements of care that are not explicitly medical – e.g. the 
psychological, social, or existential – and could inform expanded measures in the HIS 
and CAHPS to capture these critical domains of experience. 
As much as the measures themselves can be refined, quality measurement is 
meaningless if it is not used to hold providers accountable for their services. While this 
report found that on the whole CMS’ measurements fairly represent patient preference at 
end of life, the failure to report that data to the public and use it for performance-based 
rewards and penalties deeply limits its ultimate effectiveness. As long as data is not 
revealed to the public, there is no potential for reputational effects to influence providers’ 
services. And as long as data is not used, even internally, to decide on performance-based 
rewards and penalties, there will be no motivation to improve.  
                                                
142 National Consensus Project, Clinical Practice Guidelines.; Schneck et al., “The PEACE Project,” 1451.  





The infrastructure of hospice is too provider, not patient, centered, as it does not 
use measurement to hold providers accountable for their quality but is willing to limit 
eligibility for patients in order to control costs. Discussion in the health policy 
community, and CMS itself, may suggest that as the ACA develops its pay-for-
performance model, the “easing in” period for hospices will end and they, too, will be 
subject to the same rules. But patients do not have that luxury of time, and they are the 
ones who deserve quality from the very beginning. Advocacy in this regard is critical; 
without ensuring that policy follows promise and patients truly are kept at the center of 
their care, its reimbursement, and its measurement, we poorly serve them in their greatest 







The genesis of hospice care is strongly mission-driven, based in an ethical 
obligation to put a roof over the dying crusader’s head. It is recognition that dying, in its 
universality, demands equitable treatment. While we are far from equity in this country, 
attention builds on the care we provide those at the end of life and the ways in which, by 
centering care around their goals, we return some semblance of control that disease has 
otherwise taken. Progress is evident, though at times faltering. Insurance has opened the 
door to hospice for Medicare beneficiaries, but restricts those who can enter it; quality 
measurement has sought to ensure the services provided are, in fact, quality, but does not 
hold providers accountable for the performance they report; and measurement captures 
part of the patient experience but misses much of the life of the mind.   
Regardless of the distance remaining, this is progress. It encourages the 
integration of end-of-life care into the mainstream, and supports conversations about 
quality of life and care preferences in a period of life that for many of us is painful to 
consider. The goal is to make end-of-life care as person-centered and accountable as 
possible, so that it is the kind of care we would want for ourselves and our loved ones 







APPENDIX A: HOSPICE ITEM SET 
Composite Measures 
Hospice Team Communication 
  While your family member was in hospice care, how often did the hospice team keep 
you informed about when they would arrive to care for your family member? 
  While your family member was in hospice care, how often did the hospice team 
explain things in a way that was easy to understand? 
  How often did the hospice team listen carefully to you when you talked with them 
about problems with your family member’s hospice care? 
  While your family member was in hospice care, how often did the hospice team keep 
you informed about your family member’s condition? 
  While your family member was in hospice care, how often did the hospice team listen 
carefully to you? 
Getting Timely Care 
  While your family member was in hospice care, when you or your family member 
asked for help from the hospice team, how often did you get help as soon as you needed 
it? 
  How often did you get the help you needed from the hospice team during evenings, 
weekends, or holidays? 
Treating Family Member with Respect 
  While your family member was in hospice care, how often did the hospice team treat 




  While your family member was in hospice care, how often did you feel that the 
hospice team really cared about your family member? 
Providing Emotional Support 
  While your family member was in hospice care, how much emotional support did you 
get from the hospice team? 
  In the weeks after your family member died, how much emotional support did you get 
from the hospice team? 
Getting Help for Symptoms 
  Did your family member get as much help with pain as he or she needed? 
  How often did your family member get the help he or she needed for trouble 
breathing? 
  How often did your family member get the help he or she needed for trouble with 
constipation? 
  How often did your family member get the help he or she needed from the hospice 
team for feelings of anxiety or sadness? 
Getting Hospice Care Training 
  Did the hospice team give you the training you needed about what side effects to watch 
for from pain medicine? 
  Did the hospice team give you the training you needed about if and when to give more 
pain medicine to your family member? 
  Did the hospice team give you the training you needed about how to help your family 
member if he or she had trouble breathing? 
  Did the hospice team give you the training you needed about what to do if your family 




Single Item Measures 
Providing Support for Religious and Spiritual Beliefs 
  Support for religious or spiritual beliefs includes talking, praying, quiet time, or other 
ways of meeting your religious or spiritual needs. While your family member was in 
hospice care, how much support for your religious and spiritual beliefs did you get from 
the hospice team? 
Information Continuity 
  While your family member was in hospice care, how often did anyone from the 
hospice team give you confusing or contradictory information about your family 
member’s condition or care? 
Understanding the Side Effects of Pain Medication 
  Side effects of pain medicine include things like sleepiness. Did any member of the 
hospice team discuss side effects of pain medicine with you or your family member? 
Global Measures 
Overall Rating of Hospice 
  Using any number from 0 to 10, where 0 is the worst hospice care possible and 10 is 
the best hospice care possible, what number would you use to rate your family member’s 
hospice care? 
Recommend Hospice 




APPENDIX B: NQF ENDORSED MEASURES  
1634: Hospice and Palliative Care- Pain Screening (UNC) (paired with measure 1637) 
1637: Hospice and Palliative Care – Pain Assessment (UNC) (paired with measure 1634) 
1617: Patients treated with an Opioid who are given a bowel regimen (RAND) 
1628: Patients with advanced cancer assessed for pain at outpatient visits (RAND) 
1638: Hospice and Palliative Care- Dyspnea Treatment (UNC) (paired with measure 
1639) 
1639: Hospice and Palliative Care – Dyspnea Screening (UNC) (paired with measure 
1638) 
1626: Patients admitted to the ICU who have care preferences documented (RAND) 
1641: Hospice and Palliative Care- Treatment Preferences (UNC) 
1647: Percentage of hospice patients with documentation in the clinical record of a 
discussion of spiritual/religious concerns or documentation that the patient/caregiver did 
not want to discuss (Deyta) 
0209: Comfortable dying (NHPCO) (maintenance) 
1625: Hospitalized patients who die an expected death with an ICD that has been 
deactivated (RAND) 
0208: Family Evaluation of Hospice Care (NHPCO) (maintenance) 
1632: CARE- Consumer Assessments and Reports of End of Life (Center for 
Gerontology and Health Care Research) 







APPENDIX C: CAHPS HOSPICE SURVEY 
 
Composite Measures 
Hospice Team Communication 
Q1: While your family member was in hospice care, how often did the hospice team keep you informed 
about when they would arrive to care for your family member? 
Q2: While your family member was in hospice care, how often did the hospice team explain things in a 
way that was easy to understand? 
Q3: How often did the hospice team listen carefully to you when you talked with them about problems 
with your family member’s hospice care? 
Q4:  While your family member was in hospice care, how often did the hospice team keep you informed 
about your family member’s condition? 
Q5: While your family member was in hospice care, how often did the hospice team listen carefully to 
you? 
Getting Timely Care 
Q1: While your family member was in hospice care, when you or your family member asked for help 
from the hospice team, how often did you get help as soon as you needed it? 
Q2: How often did you get the help you needed from the hospice team during evenings, weekends, or 
holidays? 
Treating Family Member with Respect 
Q1: While your family member was in hospice care, how often did the hospice team treat your family 
member with dignity and respect? 
Q2: While your family member was in hospice care, how often did you feel that the hospice team really 
cared about your family member? 
Providing Emotional Support 
Q1: While your family member was in hospice care, how much emotional support did you get from the 
hospice team? 
Q2: In the weeks after your family member died, how much emotional support did you get from the 
hospice team? 
Getting Help For Symptoms 
Q1: Did your family member get as much help with pain as he or she needed? 
Q2: How often did your family member get the help he or she needed for trouble breathing? 
Q3: How often did your family member get the help he or she needed for trouble with constipation? 
Q4: How often did your family member get the help he or she needed from the hospice team for feelings 
of anxiety or sadness? 
Getting Hospice Training (In-Home Care Only) 
Q1: Did the hospice team give you the training you needed about what side effects to watch for from 
pain medicine? 
Q2: Did the hospice team give you the training you needed about if and when to give more pain 
medicine to your family member? 
Q3: Did the hospice team give you the training you needed about how to help your family member if he 
or she had trouble breathing? 
Q4: Did the hospice team give you the training you needed about what to do if your family member 
became restless or agitated? 
Single Items 
Providing Support for Religious and Spiritual Beliefs 
Q1: Support for religious or spiritual beliefs includes talking, praying, quiet time, or other ways of 




support for your religious and spiritual beliefs did you get from the hospice team? 
Information Continuity 
Q1: While your family member was in hospice care, how often did anyone from the hospice team give 
you confusing or contradictory information about your family member’s condition or care? 
Understanding Side-Effects of Pain Medication 
Q1: Side effects of pain medicine include things like sleepiness. Did any member of the hospice team 
discuss side effects of pain medicine with you or your family member? 
Global Measures 
Overall Rating of Hospice 
Q1: Using any number from 0 to 10, where 0 is the worst hospice care possible and 10 is the best 
hospice care possible, what number would you use to rate your family member’s hospice care? 
Recommend Hospice 













Abernethy, Amy. “Culture and Financing Influence Palliative Care Services, Study 
Populations, and Generalizability of Research Findings.” Journal of Palliative 
Medicine 11 (2008): 146. 
 
Agency for Healthcare Research and Quality. “Closing the Quality Gap Series: 




Aging with Dignity. “Five Wishes.” Last modified 2015. 
https://agingwithdignity.org/about-us.  
 
American Medical Association. “Average Hospice Length of Stay is Falling.” 
AMEDNEWS, February 1, 2012. 
http://www.amednews.com/article/20120201/profession/302019996/8/.  
 
American Society of Clinical Oncology. “The Debate in Hospice Care.” Journal of 
Oncology Practice 4 (2008): 153-157. 
 
Baumrucker, S., Stolick, M., Carter, G., Lasky, T., Sheldon, J., Harrington, D., 
Messerschmidt, W., Oertli, K., and Morris, G. “Death, Dying, and Statistics: Quality 
Measures Versus Quality of Life.” American Journal of Hospice and Palliative 
Medicine 27 (2010): 494-499. 
 
Belluck, P. “Coverage for End-of-life Talks Gaining Ground.” The New York Times, 
August 30, 2014. http://www.nytimes.com/2014/08/31/health/end-of-life-talks-may-
finally-overcome-politics.html?_r=0. 
 
Berwick, D., Nolan, T., and Whittington, J. “The Triple Aim: Care, Health, and Cost.” 
Health Affairs 27 (2008): 759-769. 
 
Black, B., Herr, K., Fine, P., Sanders, S., Tang, X., Bergen-Jackson, K., Titler, M., and 
Forcucci, C. “The Relationships Among Pain, Nonpain symptoms, and Quality of 
Life Measures in Older Adults with Cancer Receiving Hospice Care.” Pain Medicine 
12 (2011): 880-889. 
 
Boston, J., Bradstock, A., and Eng, D., Eds. Public Policy: Why Ethics Matter. Canberra, 





Campbell, L., Clauw, D., and Keefe, F. “Persistent Pain and Depression: A 
Biopsychosocial Perspective.” Biological Psychiatry 54 (2003): 399-409. 
 
Carlson, M., Barry, C., Cherlin, E., McCorkle, R., and Bradley, E. “Hospices’ Enrollment 
Policies May Contribute to Underuse of Hospice Care in the United States.” Health 
Affairs 31 (2012): 2690-2698. 
 
Carroll, A. “To be Sued Less, Doctors Should Consider Talking to Patients More.” The 






Centers for Medicare and Medicaid Services. “CAHPS Hospice Survey Fact Sheet.” Last 




Centers for Medicare and Medicaid Services. “FY 2016 Hospice Payment Rate Update.” 








Centers for Medicare and Medicaid Services. “Medicare Care Choices Model.” Last 
modified October 2015. https://innovation.cms.gov/initiatives/Medicare-Care-
Choices/.  
 
Detsky, A. “What Patients Really Want from Healthcare.” Journal of American Medical 
Association 36 (2011): 2500-2501. 
 
Edens, P., Harvey, C., and Gilden, K. “Developing and Financing a Palliative Care 
Program.” American Journal of Hospice and Palliative Medicine 25 (2008): 379-384. 
 
Federal Register. “Medicare Program; FY 2016 Hospice Wage Index and Payment Rate 







Gozalo, P., Plotzke, M., Mor, V., Miller, S., and Teno, J. “Changes in Medicare Costs 
With The Growth of Hospice Care in Nursing Homes.” The New England Journal of 
Medicine 372 (2015): 1823-1831. 
 
Hartjes, T. “Making The Case for Palliative Care in Critical Care.” Critical Care Nursing 
Clinics of North America 27 (2015): 289-295.  
 




Henry J. Kaiser Family Foundation. “10 FAQs: Medicare’s Role in End-of-Life Care.” 
Last modified November 2015. http://files.kff.org/attachment/fact-sheet-10-faqs-
medicares-role-in-end-of-life-care.  
 
Hibbard, J., Stockard, J., and Tusler, M. “Hospital Performance Reports: Impacts on 
Quality, Market Share, and Reputation.” HealthAffairs 24 (2005): 1150-1160. 
 
Himelstein, B., Hilden, J., Boldt, A., and Weissman, D. “Pediatric Palliative Care.” New 
England Journal of Medicine 350 (2004): 1752-1762. 
 
Hobson, C. “Why Do Patients Want Treatment That Doesn’t Work?” The Conversation, 
August 28, 2015. http://theconversation.com/why-do-patients-want-treatment-that-
doesnt-work-42633.  
 
Huskamp, H., Newhouse, J., Norcini, J., and Keating, N. “Variations in Patients’ Hospice 
Costs.” Inquiry 45 (2008): 232-244. 
 
Institute of Medicine. Dying in America: Improving Quality and Honoring Individual 





Jacobson, P. “Medical Liability and The Culture of Technology.” Pew Project on 




Jennings, B., Ryndes, T., D’Onofrio, C., and Baily, M. “Access to Hospice Care: 







Kang, T., Munson, D., Hwang, J., and Feudtner, C. “Integration of Palliative Care Into 
Care of Children with Serious Illness.” Pediatrics in Review 35 (2014): 318-325. 
 
Kelly, L., Bender, L., Harris, P., and Casarett, D. “The ‘Comfortable Dying’ Measure: 
How Patient Characteristics Affect Hospice Pain Management Quality Scores.” 
Journal of Palliative Medicine 17 (2014): 721-724. 
 
Lindley, L. “Health Care Reform and Concurrent Curative Care for Terminally Ill 
Children: A Policy Analysis.” Journal of Hospice and Palliative Nursing 13 (2011): 
81-88. 
 
Linton, J. and Feudtner, C. “What Accounts for Differences or Disparities In Pediatric 
Palliative and End-of-life Care? A Systematic Review Focusing on Possible 
Multilevel Mechanisms.” Pediatrics 122 (2008): 574-582. 
 
Lutz, S. “The History of Hospice and Palliative Care.” Current Problems in Cancer 35 
(2011): 305-309. 
 
Matsuyama, R., Reddy, S., and Smith, T. “Why Do Patients Choose Chemotherapy Near 
the End of Life? A Review of the Perspective of Those Facing Death From Cancer.” 
Journal of Clinical Oncology 24 (2006): 3490-3496.   
 
Medicare Payment Advisory Commission. “Hospice Service Payment System.” Last 
modified March 2015. http://medpac.gov/documents/reports/chapter-12-hospice-
services-(march-2015-report).pdf.   
 
Medicare Payment Advisory Commission. “Reforming Medicare’s Hospice Benefit.” 
Last modified March 2009. 
http://www.medpac.gov/documents/reports/Mar09_Ch06.pdf.  
 
Mello, M., Gawande, A., Studdert, D., and Chandra, A. “National Costs of The Medical 
Liability System.” Health Affairs 29 (2010): 1569-1577.  
 
Meyer, Harris. “Changing The Conversation in California About Care Near The End of 
Life. Health Affairs 30 (2011): 390-393. 
 
Morden, N., Chang, C., Jacobsen, J., Berke, E., Bynum, J., Murray, K., and Goodman, D. 
“End-of-life Care for Medicare Beneficiaries With Cancer Is Highly Intensive Overall 





Morrison, R., Penrod, J., Cassel, B., Caust-Ellenbogen, M., Litke, A., Spragens, L., and 
Meier, D. “Cost Savings Associated with US Hospital Palliative Care Consultation 
Programs.” Arch Intern Med 168 (2008): 1783 -1790. 
 
Nakhoda, Z. “End-of-life Care and the Medicare Hospice Benefit: The High Cost of End-
of-life Care.” Journal of Financial Service Professionals (2010): 24-28. 
 
National Association for Home Care and Hospice. “CMS Proposed FY2016 Hospice 
Payment Rule Addresses Payment Reform, Aggregate Cap Changes, Diagnoses on 
Claims.” Last modified May 2015. http://www.nahc.org/NAHCReport/nr150501_1/. 
 
National Association for Home Care and Hospice. “Hospice Background.” Last modified 
March 2016. http://www.nhpco.org/history-hospice-care.  
 
National Association for Home Care and Hospice. “Key Legislation Affecting Home 
Care and Hospice.” Last modified 2015. http://www.nahc.org/advocacy-policy/key-
legislation-affecting-home-care-and-hospice/. 
 
National Consensus Project. Clinical Practice Guidelines for Quality Palliative Care. 













National Hospice and Palliative Care Organization. “Hospice Item Set.” Last modified 
November 2015. http://www.nhpco.org/quality/hospice-item-set-his.  
  
National Hospice and Palliative Care Organization. “Quality Reporting.” Last modified 
2015. http://www.nhpco.org/quality-reporting. 
 







Niethammer, D. Speaking Honestly with Sick and Dying Children and Adolescents. 
Translated by Victoria Hill. Baltimore: Johns Hopkins University Press, 2012. 
 
Nyhan, B. “Why The ‘Death Panel’ Myth Won’t Die: Misinformation in the Health Care 
Reform Debate.” The Forum 8 (2010): 1 – 26.    
 
Obermeyer, Z., Makar, M., Abujaber, S., Dominici, F., Block, S., and Cutler, D. 
“Association Between the Medicare Hospice Benefit and Health Care Utilization and 
Costs for Patients with Poor-Prognosis Cancer.” Journal of American Medical 
Association 312 (2014): 1888-1896.  
 
Ogundimu, T. “Concurrent Care: The Buzzword in Hospice Services.” Care 




Palin, S. “Obama and The Bureaucratization of Health Care.” The Wall Street Journal, 
September 8, 2009. 
http://www.wsj.com/articles/SB10001424052970203440104574400581157986024.  
 
Passik, S., Ruggles, C., Brown, G., Snapp, J., Swinford, S., Gutgsell, T., and Kirsh, K. “Is 
There A Model for Demonstrating a Beneficial Financial Impact Of Initiating A 
Palliative Care Program By An Existing Hospice Program?” Palliative and 
Supportive Care 2 (2004): 419-423.  
 
Pear, R. “New Medicare Rule Authorizes ‘End-of-Life’ Consultations.” The New York 
Times, October 30, 2015. http://nyti.ms/1KLKbR2.  
 
Plotzke, M., Christian, T., Teno, J., and Gozalo, P. “A Review of Claims-Based Quality 
Measures Used By The Centers for Medicare and Medicaid Services and Medicare 
Administrative Contractors to Monitor the Medicare Hospice Benefit.” Journal of 
Pain and Symptom Management 51 (2016): 436-437. 
 
Pyenson, B., Connor, S., Fitch, K., and Kinzbrunner, B. “Medicare Cost in Matched 
Hospice and Non-Hospice Cohorts.” Journal of Pain and Symptom Management 28 
(2004): 200-210.  
 
Rady, M. and Johnson, D. “Admission to Intensive Care Unit at the End-of-life: Is It an 





Rotella, J. “The Devil is in the Denominator.” American Academy of Hospice and 
Palliative Medicine, February 22, 2012. http://www.aahpm.org/apps/blog/?p=1239. 
 
Schneck, A., Rokoske, F., Durham, D., Cagle, J., and Hanson, L. “The PEACE Project: 
Identification of Quality Measures for Hospice and Palliative Care.” Journal of 
Palliative Medicine 13 (2010): 1451-1460.  
 
Steinhauser, K., Christakis, N., Clipp, E., McNeilly, M., McIntyre, L., and Tulsky, J. 
“Factors Considered Important at the End of Life by Patients, Family, Physicians, and 
Other Care Providers.” Journal of American Medical Association 284 (2000): 2476-
2482. 
 
Stevenson, D. and Huskamp, H. “Hospice Payment Reforms Are a Modest Step Forward, 




Stevenson, D. “Growing Pains for the Medicare Hospice Benefit.” New England Journal 
of Medicine 367 (2012): 1683-1685. 
 
Terry, M. “The New Quality Movement in Hospice and Palliative Care: Where Is It 
Going?” Home Healthcare Nurse 32 (2014): 65-66. 
 
Thompson, J., Carlson, M., and Bradley, E. “US Hospice Industry Experienced 
Considerable Turbulence from Changes in Ownership, Growth, and Shift to For-
Profit Status.” Health Affairs 31 (2012): 1286-1247. 
 
Von Gunten, C. “Financing Palliative Care.” Clinics in Geriatric Medicine 20 (2004): 
767-781. 
 
Webb, J. and Kamal, A. “Integrating the Biopyschosocial Model into Quality Measures 
in Palliative Care: A Case for Improving the Hospice Item Set.” Journal of Pain and 
Symptom Management 48 (2014): 1-2. 
 
Weiner, R. “Sarah Palin Suggests Coin Conspiracy in Wisconsin Speech.” Huffington 
Post, March 18, 2010. http://www.huffingtonpost.com/2009/11/09/sarah-palin-
suggests-coin_n_350556.html.  
 
Weireter, E. “NQF Endorses Palliative and End-of-Life Care Measures.” National 







Wessman, B., Sona, C., and Schallom, M. “Improving Caregivers’ Perceptions Regarding 
Patient Goals of Care: End-of-life Issues for the Multidisciplinary Critical Care 
Team.” Journal of Intensive Care Medicine (2015): 1-9. 
 
Whoriskey, P. and Keating, D. “Dying and Profits: The Evolution of Hospice.” The 
Washington Post, December 26, 2014. 
https://www.washingtonpost.com/business/economy/2014/12/26/a7d90438-692f-
11e4-b053-65cea7903f2e_story.html.  
 
  
 
